Cite
APA Citation
Polistena, B., Spandonaro, F., Capra, R., Fantaccini, S., Santoni, L., Zimatore, G., & Gasperini, C. (2019). the societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri® PharmacoEconomics (TyPE) Study. Global & regional health technology assessment, 2019, . http://access.bl.uk/ark:/81055/vdc_100091634779.0x000018